Lung Cancer News and Research

Latest Lung Cancer News and Research

Endoscopic testing prior to lung cancer surgery improves quality of life

Endoscopic testing prior to lung cancer surgery improves quality of life

7 Jul 2011
Amrubicin vs. topotecan Phase III trial against lung cancer presented at IASLC conference

Amrubicin vs. topotecan Phase III trial against lung cancer presented at IASLC conference

7 Jul 2011
TGen presents two key studies at 14th World Conference on Lung Cancer

TGen presents two key studies at 14th World Conference on Lung Cancer

7 Jul 2011
Scientists reveal that 'detox' protein could trigger pancreatic, lung cancer development

Scientists reveal that 'detox' protein could trigger pancreatic, lung cancer development

7 Jul 2011
Increase in lung cancer resection rate linked to increased investment in thoracic surgical expertise

Increase in lung cancer resection rate linked to increased investment in thoracic surgical expertise

6 Jul 2011
New CRM simulation model for Canadian Partnership Against Cancer

New CRM simulation model for Canadian Partnership Against Cancer

6 Jul 2011
Review of non-smoker patient with lung cancer to be presented at IASLC conference

Review of non-smoker patient with lung cancer to be presented at IASLC conference

6 Jul 2011
Stereotactic ablative radiotherapy improves median survival for elderly Dutch NSCLC patients

Stereotactic ablative radiotherapy improves median survival for elderly Dutch NSCLC patients

6 Jul 2011
Older people, women and minorities enrolled less frequently in lung cancer drug trials

Older people, women and minorities enrolled less frequently in lung cancer drug trials

6 Jul 2011
Former smokers with lung cancer can benefit from celecoxib treatment

Former smokers with lung cancer can benefit from celecoxib treatment

6 Jul 2011
Never smokers' lung adenocarcinomas show greater genome instability

Never smokers' lung adenocarcinomas show greater genome instability

5 Jul 2011
Patients with high EGFR expression more likely to benefit from cetuximab plus chemotherapy

Patients with high EGFR expression more likely to benefit from cetuximab plus chemotherapy

5 Jul 2011
PET imaging technique may identify TKI-responsive lung cancer

PET imaging technique may identify TKI-responsive lung cancer

5 Jul 2011
LCMC finds 9.6% of lung cancer patients with ALK rearrangement

LCMC finds 9.6% of lung cancer patients with ALK rearrangement

5 Jul 2011
Erlotinib phase III study results on lung cancer presented at IASLC conference

Erlotinib phase III study results on lung cancer presented at IASLC conference

5 Jul 2011
LuCED test can improve utility of low-dose CT screening for early lung cancer detection

LuCED test can improve utility of low-dose CT screening for early lung cancer detection

4 Jul 2011
International Association for the Study of Lung Cancer welcomes publication of NLST results

International Association for the Study of Lung Cancer welcomes publication of NLST results

2 Jul 2011
Low-dose spiral CT scan can decrease mortality from lung cancer

Low-dose spiral CT scan can decrease mortality from lung cancer

1 Jul 2011
Avastin for breast cancer still covered by Medicare despite FDA indecision

Avastin for breast cancer still covered by Medicare despite FDA indecision

1 Jul 2011
Study confirms benefits of low-dose spiral CT scans for lung cancer detection

Study confirms benefits of low-dose spiral CT scans for lung cancer detection

30 Jun 2011

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback